ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
108.340 IP-LS
Project title
Mitochondrial Pyruvate Carrier inhibitors (MPCi) to treat Alzheimer?s disease.

Participants

Research organisation: Innosuisse
Swiss Innovation Agency
Einsteinstrasse 2
CH-3003 Bern
+41 58 461 61 61 (Call Center)
info@innosuisse.ch
www.innosuisse.ch/
Contact person

 Martinou Raphael
MPC Therapeutics SA
www.uid.admin.ch/Detail.aspx?uid_id=CHE432161098

Scientific management
UNIL - Université de Lausanne

Implementation Partner


MPC Therapeutics SA
www.uid.admin.ch/Detail.aspx?uid_id=CHE432161098